IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice | |
Wu, Rui; Liu, Xuanchen; Yin, Jianyong; Wu, Huijuan; Cai, Xiulei; Wang, Niansong; Qian, Youcun; Wang, Feng | |
刊名 | METABOLISM-CLINICAL AND EXPERIMENTAL |
2018 | |
卷号 | 83 |
关键词 | IL-6 Tocilizumab Inflammation NLRP3 inflammasome IL-17A Biologics |
ISSN号 | 0026-0495 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3609436 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wu, Rui,Liu, Xuanchen,Yin, Jianyong,et al. IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice[J]. METABOLISM-CLINICAL AND EXPERIMENTAL,2018,83. |
APA | Wu, Rui.,Liu, Xuanchen.,Yin, Jianyong.,Wu, Huijuan.,Cai, Xiulei.,...&Wang, Feng.(2018).IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice.METABOLISM-CLINICAL AND EXPERIMENTAL,83. |
MLA | Wu, Rui,et al."IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice".METABOLISM-CLINICAL AND EXPERIMENTAL 83(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论